DA Davidson lowered the firm’s price target on BlueLinx (BXC) to $75 from $80 and keeps a Neutral rating on the shares. The stock traded modestly lower since reporting Q2 results despite a better than feared performance in a tough environment, the analyst tells investors in a research note. The silver linings for BlueLinx included y/y volume gains in both segments, fueled in part by execution within multi-family, as well as a relatively stable gross margin performance in Specialty Products, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BXC: